Download presentation
Presentation is loading. Please wait.
Published byVera Budiono Modified over 6 years ago
1
Anti-inflammatory effect of itraconazole in stable allergic bronchopulmonary aspergillosis: A randomized controlled trial Peter Alexander Blanch Wark, BMed, PhD, FRACPa, Michael John Hensley, MBBS, PhD, FRACP, FAFPHMa, Nicholas Saltos, MBBS, FRACP, FRCP, FRCPI, FCCPa, Michael James Boyle, MD, FRACP, FRCPAb, Ruth Christine Toneguzzi, Grad Dip Clin Epid, a, Jodie Louise Simpson, BSc (Hons)a, Patrick McElduff, PhDc, Peter Gerard Gibson, MBBS, FRACPa Journal of Allergy and Clinical Immunology Volume 111, Issue 5, Pages (May 2003) DOI: /mai Copyright © 2003 Mosby, Inc. Terms and Conditions
2
Fig. 1 Sputum eosinophils (percentage) at each treatment period in subjects treated with itraconazole or placebo. All values are expressed as the mean and 95% CI. The data were log transformed, and the mean reported is the mean of the log value. The antilog of this value has been recorded to provide meaningful results. Journal of Allergy and Clinical Immunology , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions
3
Fig. 2 Sputum ECP levels (in nanograms per milliliter) in subjects treated with itraconazole or placebo. All values are expressed as the mean and 95% CI. The data were log transformed, and the mean reported is the mean of the log value. The antilog of this value has been recorded to show meaningful results. Journal of Allergy and Clinical Immunology , DOI: ( /mai ) Copyright © 2003 Mosby, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.